<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Bioengineering</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/45555183-99CB-4B93-BB81-CE9DDF06CF7E"><gtr:id>45555183-99CB-4B93-BB81-CE9DDF06CF7E</gtr:id><gtr:name>Lonza Biologics</gtr:name><gtr:address><gtr:line1>228 Bath Road</gtr:line1><gtr:line4>Slough</gtr:line4><gtr:postCode>SL1 4DX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/FA6FAA88-BC7C-4389-A3F1-97975163D7E7"><gtr:id>FA6FAA88-BC7C-4389-A3F1-97975163D7E7</gtr:id><gtr:name>Shell Global Solutions UK</gtr:name><gtr:address><gtr:line1>Shell Technology Centre</gtr:line1><gtr:line2>Thornton</gtr:line2><gtr:line3>PO Box 1</gtr:line3><gtr:line4>Chester</gtr:line4><gtr:line5>Cheshire</gtr:line5><gtr:postCode>CH1 3SH</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3E32B22B-ACAC-468E-A37D-47E5D28813B9"><gtr:id>3E32B22B-ACAC-468E-A37D-47E5D28813B9</gtr:id><gtr:name>Dr Reddy's Laboratories UK Ltd</gtr:name><gtr:address><gtr:line1>410 Cambridge Park</gtr:line1><gtr:line2>Milton Road</gtr:line2><gtr:postCode>CB4 0PE</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5B9542CC-D7F0-45DA-A423-16458386EA25"><gtr:id>5B9542CC-D7F0-45DA-A423-16458386EA25</gtr:id><gtr:name>GlaxoSmithKline PLC</gtr:name><gtr:address><gtr:line1>Park Road</gtr:line1><gtr:postCode>SG12 0DP</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/44AA8695-2005-41D7-A759-C8A1C6814524"><gtr:id>44AA8695-2005-41D7-A759-C8A1C6814524</gtr:id><gtr:firstName>Thomas</gtr:firstName><gtr:surname>Welton</gtr:surname><gtr:orcidId>0000-0002-1750-1683</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F89ADA6C-35D9-413C-B7E2-FB467F123B08"><gtr:id>F89ADA6C-35D9-413C-B7E2-FB467F123B08</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Kitney</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D7E9C1F0-D945-4C6E-A909-C32B3F6AAF99"><gtr:id>D7E9C1F0-D945-4C6E-A909-C32B3F6AAF99</gtr:id><gtr:firstName>Donal</gtr:firstName><gtr:otherNames>Donat</gtr:otherNames><gtr:surname>Bradley</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A26059BF-EAB2-4EED-9A0A-6E427D39A173"><gtr:id>A26059BF-EAB2-4EED-9A0A-6E427D39A173</gtr:id><gtr:firstName>Karen</gtr:firstName><gtr:otherNames>Marie</gtr:otherNames><gtr:surname>Polizzi</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/BF38F494-1ADA-4B3B-BB99-00513E314F71"><gtr:id>BF38F494-1ADA-4B3B-BB99-00513E314F71</gtr:id><gtr:firstName>Travis</gtr:firstName><gtr:otherNames>Scott</gtr:otherNames><gtr:surname>Bayer</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B8277CE4-2ACC-473D-A5B0-5E15DFB615A6"><gtr:id>B8277CE4-2ACC-473D-A5B0-5E15DFB615A6</gtr:id><gtr:firstName>Nilay</gtr:firstName><gtr:surname>Shah</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/5468C445-14FE-41FD-8340-F14BC24AD653"><gtr:id>5468C445-14FE-41FD-8340-F14BC24AD653</gtr:id><gtr:firstName>Cleo</gtr:firstName><gtr:surname>Kontoravdi</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F1BF75F0-C952-4A52-A437-5A52F79EF29C"><gtr:id>F1BF75F0-C952-4A52-A437-5A52F79EF29C</gtr:id><gtr:firstName>Oscar</gtr:firstName><gtr:surname>Ces</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/67CF102C-0AAF-48FE-9372-A900CBDDAB19"><gtr:id>67CF102C-0AAF-48FE-9372-A900CBDDAB19</gtr:id><gtr:firstName>Jason</gtr:firstName><gtr:otherNames>Patrick</gtr:otherNames><gtr:surname>Hallett</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/00F59590-07CD-44C6-AEFD-33E298C6D0A4"><gtr:id>00F59590-07CD-44C6-AEFD-33E298C6D0A4</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>S</gtr:otherNames><gtr:surname>Freemont</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=EP%2FK038648%2F1"><gtr:id>5C2C1C09-3E85-44CB-A36A-2E0508B290DA</gtr:id><gtr:title>Frontier Manufacturing: Scaling up synthetic biology</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/K038648/1</gtr:grantReference><gtr:abstractText>Synthetic biology has the potential to revolutionise the way we make a host of consumer products from materials and energy to food and medicine. In order for this impact to be realised, we must find the best way to translate laboratory discoveries into operating industrial production processes. The challenge here is to transition from existing factories into the factories of the future. 

Today many consumer products are made from fossil resources using synthetic chemistry techniques. In the future we will need to reduce our dependence on petroleum products and move to renewable resources. At the same time, the advent of synthetic biology techniques for rapidly tailoring biological systems for manufacturing purposes will allow us to transition away from synthetic chemistry and into more environmentally friendly production mechanisms using cells. We will tackle the question of how to undergo this transition smoothly by working with our industrial partners on real-world applications in two consumer areas (therapeutics and chemicals manufacturing). 

Developing these future biofactories will require the invention of some new generalised technologies to underpin the new manufacturing processes. We will need new biologically based sensors in order to be able to monitor the production processes as they occur to ensure the product quality (and to allow us to intervene if necessary). We will also need new, more robust production cells that can tolerate the high levels of compounds they make and new microreactors and/or compartmentalisation strategies for using enzymes when whole cells are not required. Because the transition will not happen overnight, we will need to develop intermediate production methods that combine biological and chemical catalysts. This will require solvents that are less toxic to proteins and cells and proteins that are engineered to be more robust in the presence of chemicals. In order to develop processes that are economical and efficient (minimal energy and water usage), we will create computer models to compare alternatives. The most promising processes will be implemented in the factories of our industrial partners. 

We have chosen two challenge areas in which to test our new technologies. The first is healthcare, specifically the manufacture of medicinal compounds and therapeutic proteins. These are already largely made using biological systems, but the existing processes are expensive and complicated. Also, in the future, it would be more efficient to make these medicines as and when they are needed (point-of-care manufacture). Our goals are to make simpler, more cost effective, point-of-care manufacturing systems using a combination of the above mentioned platform technologies: enzyme microreactors, specialised cells, and biosensors. 

Our second target is to produce bulk chemicals without the need for petroleum inputs. This will require us to adjust our manufacturing techniques for renewable inputs (such as biomass) and to develop new processes that use biology and/or environmentally friendly chemistry to do the conversions. Synthetic biology has never been attempted on such a large scale. Our challenge will be to adapt our parts, devices, and systems to operate at this level. 

The overall outcome will be novel, cost effective, energy efficient, and sustainable routes to therapeutics and chemicals.</gtr:abstractText><gtr:potentialImpactText>The development of synthetic chemistry in the 19th and 20th centuries resulted in many of the major industries of today. These industries largely rely on oil as their basic feedstock. The fragility of oil supply has led a need to reengineer the chemicals industry to use bio-based feedstocks. Synthetic biology can make a major contribution to this. 
 
At Imperial College's Centre for Synthetic Biology and Innovation, together with national and international colleagues, we have been developing platform technologies which are applicable across a range of industrial fields. This comprises novel wet lab techniques for DNA assembly, BioPart characterisation and Host Cell (Chassis) development - as well as a web-based synthetic biology information system (SynBIS) comprising a professional registry of BioParts, Models and BioCAD design tools. Imperial's Departments of Chemical Engineering and Chemistry are both internationally renowned for their industrially-relevant innovation in chemicals manufacturing, process development and design, and the translation of this to industrial application. This project is to address the challenge of taking synthetic biology from the laboratory bench to the chemicals manufacturing plant. We will ensure this by cutting edge research and innovation, translation underpinned by deep industrial user engagement and the development of future leaders, as described in the Case for Support and Pathways to Impact Statement. 
 
We anticipate our work will benefit a wide range of stakeholders including: synthetic biologists, chemical and energy companies, materials manufacturers and the broader chemical industries, as well as consumers interested in new products developed through the exploitation of synthetic biology. Our proposed project will demonstrate to this broad base of stakeholders the opportunities and benefits of novel hybrid chemo-biological processes, and compute performance benchmarks by which novel processes can be compared against existing process chains. 

In order to ensure this impact, we have already involved several industrial partners (GSK, Shell, Lonza, Dr Reddy) as initial stakeholders in our research programme. Representatives from each of these companies will be closely involved in helping to shape and critique our activities, advising us on pathways to commercialisation and ensuring we maximise the impact of our research efforts. 
 
As this research is primarily aimed at developing manufacturing processes using synthetic biology, we anticipate a substantial impact on the future landscape of the UK manufacturing sector. The material routes and practices developed in this type of research represent potential economic impact by developing secure routes of material and chemical manufacturing within the UK. Breaking our dependence on fossil reserves will also necessarily create new manufacturing industries and also reduce our dependence on imported goods. Introducing novel synthetic biology practices will also revolutionise the existing manufacturing industries. 
 
There is great training potential within this project. As we will be employing 12 full-time researchers in the programme, we will be furthering the dissemination of synthetic biology principles into the employment sector. This will influence future manufacturing directions as the propagation of these future research and development leaders into industry is inevitable. 
 
The extensive timeline of this programme (five years) will enable us to have a sustained impact on manufacturing practices and policies, as we will be able to extend our vision into industry (through our project partners) and public policy (through our advisory institutes). The value of these goals cannot be overstated - the impact of academic research can only be realized if the support of government agencies and the UK public is evident. This requires long-term commitments to the research principles we have outlined within this programme.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-10-13</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2013-10-14</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>5158504</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Imperial College Festival</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8CD3056B-3734-4D26-9003-42C03AE49154</gtr:id><gtr:impact>Public introduced to new emerging disruptive technology - Engineering Biology. Engineering of Biology to make really useful stuff. For example, seeing virtual reality labs and an introduction to new science that affects every day life. Including children's competitions, interactive technologies for all.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.imperial.ac.uk/festival/about/festival-2016/</gtr:url><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Leadership Excellence Accelerator Programme (LEAP)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>25F12FED-A653-4FBC-8D7A-5891F3B41ED3</gtr:id><gtr:impact>Each year about twenty Fellows - emerging leaders working in diverse areas of biotechnology - are selected to participate. 

LEAP envisions catalysing a next generation of leaders in synthetic biology by providing the environment to learn skills for engaging a broad range of stakeholders in the development of the field with a strong ethical foundation for the future.
LEAP does this by:
Investing in the individuals who will ultimately shape and govern this diverse, growing and globally distributed technology.
Providing them with new tools and networks essential to achieving their visions for promoting innovation responsibly in practice.
Acting as a sustaining nexus of resources and support as leaders assume their roles.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:url>http://www.synbicite.com/knowledge/leap/</gtr:url><gtr:year>2014,2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>iGEM competition and jamboree (UK &amp; US)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CCFDE7AE-5FE6-482F-A218-6402B5731D71</gtr:id><gtr:impact>The iGEM Competition is the premiere student team competition in Synthetic Biology.. 

For over 10 years, iGEM has been encouraging students to work together to solve real-world challenges by building genetically engineered biological systems with standard, interchangeable parts. Student teams design, build and test their projects over the summer and gather to present their work and compete at the annual Jamboree. 

Participation in the iGEM competition empowers teams to manage their own projects, advocate for their research and secure funding. Teams are also challenged to actively consider and address the safety, security and environmental implications of their work.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:url>http://2016.igem.org/Main_Page</gtr:url><gtr:year>2014,2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>PAS 246 - Use of standards for digital biological information in the design, construction and description of a synthetic biological system - Guide</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>0FC816A4-0F30-43F2-9984-691163130AF6</gtr:id><gtr:impact>PAS 246 - Use of standards for digital biological information in the design, construction and description of a synthetic biological system. Is a standard and guide to the development and use of data pertinent to bio-manufacturing and biotechnology</gtr:impact><gtr:type>Implementation circular/rapid advice/letter to e.g. Ministry of Health</gtr:type><gtr:url>http://shop.bsigroup.com/ProductDetail/?pid=000000000030303883</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>UK Synthetic Biology Strategic Plan 2016 - Biodesign for the Bioeconomy.</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>8996BEAB-CD84-4F81-87F6-809C9F087D96</gtr:id><gtr:impact>Minister for Life Sciences George Freeman MP visited SynbiCITE at Imperial College London, the UK innovation and knowledge centre for synthetic biology, on 24th February 2016 to announce the release of the UK Synthetic Biology Strategic Plan 2016 - Biodesign for the Bioeconomy.
This strategic plan, published by the Synthetic Biology Leadership Council (SBLC), aims to accelerate the commercialisation of synthetic biology products and services with clear public benefit, building upon the strength of the UK research base. It focuses on five key areas of strategic importance:
Accelerating industrialisation and commercialisation
Maximising the capability of the innovation pipeline
Building an expert workforce
Developing a supportive business environment, and
Building value from national and international partnerships.
It builds on the recommendations made in the Synthetic Biology Roadmap for the UK, which was first published by Innovate UK in 2012. The roadmap led directly to major funding and policy activities, including the establishment of new synthetic biology research centres, the Innovation and Knowledge Centre at SynbiCITE, DNA synthesis facilities, training centres and a seed fund for innovative companies. In addition, the Synthetic Biology Leadership Council (SBLC) was founded to manage the continued growth of this field.
During 2015, the Synthetic Biology Leadership Council (SBLC) consulted a broad cross-section of businesses and the research community to develop this new strategic plan, building upon the successes of the 2012 roadmap.</gtr:impact><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>https://connect.innovateuk.org/documents/2826135/31405930/BioDesign+for+the+Bioeconomy+2016+DIGITAL+updated+21_03_2016.pdf/d0409f15-bad3-4f55-be03-430bc7ab4e7e</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>A Synthetic Biology Roadmap for the UK</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>F551ED60-BD6A-4FBB-A836-EF875C6E94F4</gtr:id><gtr:impact>This report provides the vision and direction for supporting a world-leading synthetic biology community in the UK. Produced by an independent panel of experts for the government's Department for Business Innovation and Skills, it sets out a shared vision for realising the potential of synthetic biology in the UK.

The roadmap aims to deliver a synthetic biology sector that is cutting edge; economically vibrant, diverse and sustainable; and of clear public benefit. Recommendations in the roadmap also provide a compass-bearing for the synthetic biology community, helping to align interests towards future growth opportunities, whilst identifying the resources and support needed to accelerate progress in the shorter term.</gtr:impact><gtr:type>Membership of a guideline committee</gtr:type><gtr:url>http://www.rcuk.ac.uk/publications/reports/syntheticbiologyroadmap/</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9EA8BCE1-D638-4421-B090-650944C45BEB"><gtr:id>9EA8BCE1-D638-4421-B090-650944C45BEB</gtr:id><gtr:title>Co-culture systems and technologies: taking synthetic biology to the next level.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/27a498d16c6bdb1937b08f971e8ab104"><gtr:id>27a498d16c6bdb1937b08f971e8ab104</gtr:id><gtr:otherNames>Goers L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/18A9282F-31F7-4C63-AD74-E5CD79BF9407"><gtr:id>18A9282F-31F7-4C63-AD74-E5CD79BF9407</gtr:id><gtr:title>A microfluidic platform for size-dependent generation of droplet interface bilayer networks on rails.</gtr:title><gtr:parentPublicationTitle>Biomicrofluidics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3c85e3c377d469a5588b30b7aeee530e"><gtr:id>3c85e3c377d469a5588b30b7aeee530e</gtr:id><gtr:otherNames>Carreras P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-1058</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E0C07D49-92A5-4AA3-BD58-BAB6C1666988"><gtr:id>E0C07D49-92A5-4AA3-BD58-BAB6C1666988</gtr:id><gtr:title>Preparation and mechanical characterisation of giant unilamellar vesicles by a microfluidic method.</gtr:title><gtr:parentPublicationTitle>Lab on a chip</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b2b64f2014aacd3f059ef8fc91963217"><gtr:id>b2b64f2014aacd3f059ef8fc91963217</gtr:id><gtr:otherNames>Karamdad K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1473-0189</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4AB7A4F3-55C0-4461-A9B4-947EA3A997CD"><gtr:id>4AB7A4F3-55C0-4461-A9B4-947EA3A997CD</gtr:id><gtr:title>Industry 4.0: a vision for personalized medicine supply chains?</gtr:title><gtr:parentPublicationTitle>Cell and Gene Therapy Insights</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0672ee3a8ecaf204cfd2681f68f55221"><gtr:id>0672ee3a8ecaf204cfd2681f68f55221</gtr:id><gtr:otherNames>Branke J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/81C28E9C-5FD4-4A37-93E4-B6D5D6FC2A59"><gtr:id>81C28E9C-5FD4-4A37-93E4-B6D5D6FC2A59</gtr:id><gtr:title>EcoFlex: A Multifunctional MoClo Kit for E.&amp;nbsp;coli Synthetic Biology.</gtr:title><gtr:parentPublicationTitle>ACS synthetic biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b7c4bb13d94142ba89cd9e405efef84a"><gtr:id>b7c4bb13d94142ba89cd9e405efef84a</gtr:id><gtr:otherNames>Moore SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2161-5063</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/75915246-EAC3-41BA-81FD-829AF489661D"><gtr:id>75915246-EAC3-41BA-81FD-829AF489661D</gtr:id><gtr:title>Measurements of the effect of membrane asymmetry on the mechanical properties of lipid bilayers.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fd736bcc2e432de71bf435bf4b94d711"><gtr:id>fd736bcc2e432de71bf435bf4b94d711</gtr:id><gtr:otherNames>Elani Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EFD5DEE1-FD4C-4121-8745-36FCEC4986CD"><gtr:id>EFD5DEE1-FD4C-4121-8745-36FCEC4986CD</gtr:id><gtr:title>Vesicle-based artificial cells as chemical microreactors with spatially segregated reaction pathways.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fd736bcc2e432de71bf435bf4b94d711"><gtr:id>fd736bcc2e432de71bf435bf4b94d711</gtr:id><gtr:otherNames>Elani Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9B761A09-48A8-4E18-B0CE-A4E263A7F86A"><gtr:id>9B761A09-48A8-4E18-B0CE-A4E263A7F86A</gtr:id><gtr:title>Optically assembled droplet interface bilayer (OptiDIB) networks from cell-sized microdroplets.</gtr:title><gtr:parentPublicationTitle>Soft matter</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7ab2919b465ba7ada12b5675eacffcf7"><gtr:id>7ab2919b465ba7ada12b5675eacffcf7</gtr:id><gtr:otherNames>Friddin MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1744-683X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D4C2D4B3-279C-4D91-977F-AE7360F1EB00"><gtr:id>D4C2D4B3-279C-4D91-977F-AE7360F1EB00</gtr:id><gtr:title>Solubilizing and Stabilizing Proteins in Anhydrous Ionic Liquids through Formation of Protein-Polymer Surfactant Nanoconstructs.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/aa3dfe67b0745bed45e34f0bc6e9a223"><gtr:id>aa3dfe67b0745bed45e34f0bc6e9a223</gtr:id><gtr:otherNames>Brogan AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EB5D1A8E-7F29-407C-A670-F0629756118F"><gtr:id>EB5D1A8E-7F29-407C-A670-F0629756118F</gtr:id><gtr:title>Genetically-encoded biosensors for monitoring cellular stress in bioprocessing.</gtr:title><gtr:parentPublicationTitle>Current opinion in biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b61572c44b1605dbab38ef413ee8b493"><gtr:id>b61572c44b1605dbab38ef413ee8b493</gtr:id><gtr:otherNames>Polizzi KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0958-1669</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A7639030-AC41-4902-83EE-1324E66528CB"><gtr:id>A7639030-AC41-4902-83EE-1324E66528CB</gtr:id><gtr:title>Microfluidic generation of encapsulated droplet interface bilayer networks (multisomes) and their use as cell-like reactors.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fd736bcc2e432de71bf435bf4b94d711"><gtr:id>fd736bcc2e432de71bf435bf4b94d711</gtr:id><gtr:otherNames>Elani Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/256039B7-33EF-42E4-BDDF-E3A8F94EE2BF"><gtr:id>256039B7-33EF-42E4-BDDF-E3A8F94EE2BF</gtr:id><gtr:title>Protein synthesis in artificial cells: using compartmentalisation for spatial organisation in vesicle bioreactors.</gtr:title><gtr:parentPublicationTitle>Physical chemistry chemical physics : PCCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fd736bcc2e432de71bf435bf4b94d711"><gtr:id>fd736bcc2e432de71bf435bf4b94d711</gtr:id><gtr:otherNames>Elani Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1463-9076</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1F343AA0-E555-40A2-9F7F-829CFE57A7A7"><gtr:id>1F343AA0-E555-40A2-9F7F-829CFE57A7A7</gtr:id><gtr:title>Microfluidic generation of encapsulated droplet interface bilayer networks (multisomes) and their use as cell-like reactors.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fd736bcc2e432de71bf435bf4b94d711"><gtr:id>fd736bcc2e432de71bf435bf4b94d711</gtr:id><gtr:otherNames>Elani Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4B7363E3-3F1A-42B9-9D56-041E9690BB51"><gtr:id>4B7363E3-3F1A-42B9-9D56-041E9690BB51</gtr:id><gtr:title>Optically assembled droplet interface bilayer (OptiDIB) networks from cell-sized microdroplets.</gtr:title><gtr:parentPublicationTitle>Soft matter</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7ab2919b465ba7ada12b5675eacffcf7"><gtr:id>7ab2919b465ba7ada12b5675eacffcf7</gtr:id><gtr:otherNames>Friddin MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1744-683X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A86C7C2B-1E71-4172-B331-FD59654BD32A"><gtr:id>A86C7C2B-1E71-4172-B331-FD59654BD32A</gtr:id><gtr:title>Protein synthesis in artificial cells: using compartmentalisation for spatial organisation in vesicle bioreactors.</gtr:title><gtr:parentPublicationTitle>Physical chemistry chemical physics : PCCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fd736bcc2e432de71bf435bf4b94d711"><gtr:id>fd736bcc2e432de71bf435bf4b94d711</gtr:id><gtr:otherNames>Elani Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1463-9076</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BBE775BC-C3D4-4220-9F8A-05A1653DB110"><gtr:id>BBE775BC-C3D4-4220-9F8A-05A1653DB110</gtr:id><gtr:title>Vesicle-based artificial cells as chemical microreactors with spatially segregated reaction pathways.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fd736bcc2e432de71bf435bf4b94d711"><gtr:id>fd736bcc2e432de71bf435bf4b94d711</gtr:id><gtr:otherNames>Elani Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3933148B-905E-4FA2-AE33-E04E08F11A8D"><gtr:id>3933148B-905E-4FA2-AE33-E04E08F11A8D</gtr:id><gtr:title>Preparation and mechanical characterisation of giant unilamellar vesicles by a microfluidic method.</gtr:title><gtr:parentPublicationTitle>Lab on a chip</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b2b64f2014aacd3f059ef8fc91963217"><gtr:id>b2b64f2014aacd3f059ef8fc91963217</gtr:id><gtr:otherNames>Karamdad K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1473-0189</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8261DEA1-5811-4E80-83B5-AC4B671E9C03"><gtr:id>8261DEA1-5811-4E80-83B5-AC4B671E9C03</gtr:id><gtr:title>Designing an Artificial Golgi reactor to achieve targeted glycosylation of monoclonal antibodies</gtr:title><gtr:parentPublicationTitle>AIChE Journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ad59bcc9e14b9b429b112f97723628e3"><gtr:id>ad59bcc9e14b9b429b112f97723628e3</gtr:id><gtr:otherNames>Klymenko O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/030D7664-A2E9-4406-B7A5-988782F9B080"><gtr:id>030D7664-A2E9-4406-B7A5-988782F9B080</gtr:id><gtr:title>Pretreatment of Lignocellulosic Biomass with Low-cost Ionic Liquids.</gtr:title><gtr:parentPublicationTitle>Journal of visualized experiments : JoVE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e2d2e80e5ba71e351d16e5e4234a30a2"><gtr:id>e2d2e80e5ba71e351d16e5e4234a30a2</gtr:id><gtr:otherNames>Gschwend FJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1940-087X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4A6FDE74-7BE0-4756-9F19-541EEECC7B9F"><gtr:id>4A6FDE74-7BE0-4756-9F19-541EEECC7B9F</gtr:id><gtr:title>Microfluidic generation of droplet interface bilayer networks incorporating real-time size sorting in linear and non-linear configurations.</gtr:title><gtr:parentPublicationTitle>Biomicrofluidics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3c85e3c377d469a5588b30b7aeee530e"><gtr:id>3c85e3c377d469a5588b30b7aeee530e</gtr:id><gtr:otherNames>Carreras P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-1058</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8FC95E7F-5522-48FA-8A35-4365AF89A8E8"><gtr:id>8FC95E7F-5522-48FA-8A35-4365AF89A8E8</gtr:id><gtr:title>Vesicle-based artificial cells: recent developments and prospects for drug delivery.</gtr:title><gtr:parentPublicationTitle>Therapeutic delivery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fd736bcc2e432de71bf435bf4b94d711"><gtr:id>fd736bcc2e432de71bf435bf4b94d711</gtr:id><gtr:otherNames>Elani Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-5990</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/K038648/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>60EBB420-734E-4DB5-B0F2-65A1115A27F8</gtr:id><gtr:percentage>60</gtr:percentage><gtr:text>Chemical synthesis</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>EB5F16BB-2772-4DDE-BD6C-3B7A6914B64C</gtr:id><gtr:percentage>10</gtr:percentage><gtr:text>Info. &amp; commun. Technol.</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>99E0B904-CAB5-4511-AFB3-AA6D2B171F97</gtr:id><gtr:percentage>30</gtr:percentage><gtr:text>Process engineering</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>9C387DA5-CD5F-43E4-AA74-82CBF4DB6617</gtr:id><gtr:percentage>30</gtr:percentage><gtr:text>Bioprocess Engineering</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>1D259BA3-9B9F-4983-810F-15F2177E2A51</gtr:id><gtr:percentage>10</gtr:percentage><gtr:text>Microsystems</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>DF4CD176-73D5-4039-BBC7-28D33DC364DD</gtr:id><gtr:percentage>60</gtr:percentage><gtr:text>Synthetic biology</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>